Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells

Brain Pathology

Volumn 22, Issue 2, 2012, Pages 175-187

  Elali, Ayman ^a   Hermann, Dirk M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

ATP binding cassette transporter; blood brain barrier; brain edema; calpain 1 2; focal cerebral ischemia; middle cerebral artery occlusion; Rho GTPase; tight junction

Indexed keywords

ABC TRANSPORTER; CALPASTATIN; CATENIN; GELATINASE A; GELATINASE B; LIVER X RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 9; MULTIDRUG RESISTANCE PROTEIN 1; OCCLUDIN; PROTEIN ABCC1; PROTEIN CDC42; PROTEIN ZO1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALS; BENZOIC ACIDS; BENZYLAMINES; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HYDROCARBONS, FLUORINATED; MICE; MICE, INBRED C57BL; MIDDLE CEREBRAL ARTERY; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; ORPHAN NUCLEAR RECEPTORS; P-GLYCOPROTEIN; SULFONAMIDES; TIGHT JUNCTIONS; UP-REGULATION;

EID: 84857647007     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00517.x     Document Type: Article

References (43)

1. Anastasiadis PZ, Moon SY, Thoreson MA, Mariner DJ, Crawford HC, Zheng Y, Reynolds AB, (2000) Inhibition of RhoA by p120 catenin. Nat Cell Biol 2: 637-644.
2. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr BA, et al, (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem 276: 10191-10198.
3. Bradley MN, Hong C, Chen M, Joseph SB, Wilpitz DC, Wang X, et al, (2007) Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE. J Clin Invest 117: 2337-2346.
4. Cao G, Xing J, Xiao X, Liou AK, Gao Y, Yin XM, et al, (2007) Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci 27: 9278-9293.
5. Cau J, Hall A, (2005) Cdc42 controls the polarity of the actin and microtubule cytoskeletons through two distinct signal transduction pathways. J Cell Sci 118: 2579-2587.
6. Chen Y, Lu Q, Schneeberger EE, Goodenough DA, (2000) Restoration of tight junction structure and barrier function by downregulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 11: 849-862.
7. Chrissobolis S, Sobey CG, (2006) Recent evidence for an involvement of rho-kinase in cerebral vascular disease. Stroke 37: 2174-2180.
8. Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, et al, (2002) Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines. J Med Chem 45: 1963-1966.
9. Efanov AM, Sewing S, Bokvist K, Gromada J, (2004) Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 53: S75-S78.
10. ElAli A, Hermann DM, (2010) Apolipoprotein-E controls ATP-binding cassette transporters in the ischemic brain. Sci Signal 3: ra72.
11. Etienne-Manneville S, Hall A, (2002) Rho GTPases in cell biology. Nature 420: 629-635.
12. Fukuhara A, Shimizu K, Kawakatsu T, Fukuhara T, Takai Y, (2003) Involvement of nectin-activated Cdc42 small G protein in organization of adherens and tight junctions in Madin-Darby canine kidney cells. J Biol Chem 278: 51885-51893.
13. Goll DE, Thompson VF, Li H, Wei W, Cong J, (2003) The calpain system. Physiol Rev 83: 731-801.
14. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, et al, (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297: 1186-1190.
15. Hawkins BT, Davis TP, (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57: 173-185.
16. Hermann DM, Bassetti CL, (2007) Implications of ATP-binding cassette transporters for brain pharmacotherapies. Trends Pharmacol Sci 28: 128-134.
17. Hermann DM, Kilic E, Spudich A, Krämer SD, Wunderli-Allenspach H, Bassetti CL, (2006) Role of drug efflux carriers in the healthy and diseased brain. Ann Neurol 60: 489-498.
18. Hirase T, Kawashima S, Wong EY, Ueyama T, Rikitake Y, Tsukita S, et al, (2001) Regulation of tight junction permeability and occludin phosphorylation by RhoA-p160 ROCK-dependent and -independent mechanisms. J Biol Chem 276: 10423-10431.
19. Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP, (2004) T0901317 is a dual LXR/FXR agonist. Mol Genet Metab 83: 184-187.
20. Huber JD, Egleton RD, Davis TP, (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24: 719-725.
21. Hummasti S, Laffitte BA, Watson MA, Galardi C, Chao LC, Ramamurthy L, et al, (2004) Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target. J Lipid Res 45: 616-625.
22. Kilic E, Spudich A, Kilic U, Rentsch KM, Vig R, Matter CM, et al, (2008) ABCC1: a gateway for pharmacological compounds to the ischaemic brain. Brain 131: 2679-2689.
23. Langmann T, Mauerer R, Schmitz G, (2006) Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation. Clin Chem 52: 310-313.
24. Löscher W, Potschka H, (2005) Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6: 591-602.
25. Machacek M, Hodgson L, Welch C, Elliott H, Pertz O, Nalbant P, et al, (2009) Coordination of Rho GTPase activities during cell protrusion. Nature 461: 99-103.
26. Morales JR, Ballesteros I, Deniz JM, Hurtado O, Vivancos J, Nombela F, et al, (2008) Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation 118: 1450-1459.
27. Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, et al, (2006) Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291: H2825-H2835.
28. Naik SU, Wang X, Da Silva JS, Jaye M, Macphee CH, Reilly MP, et al, (2006) Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation 113: 90-97.
29. Neuwelt E, Abbott NJ, Abrey L, Banks WA, Blakley B, Davis T, et al, (2008) Strategies to advance translational research into brain barriers. Lancet Neurol 7: 84-96.
30. Noren NK, Liu BP, Burridge K, Kreft B, (2000) p120 catenin regulates the actin cytoskeleton via Rho family GTPases. J Cell Biol 150: 567-580.
31. Ohno H, Uemura K, Shintani-Ishida K, Nakamura M, Inomata M, Yoshida K, (2007) Ischemia promotes calpain-mediated degradation of p120-catenin in SH-SY5Y cells. Biochem Biophys Res Commun 353: 547-552.
32. Park KP, Rosell A, Foerch C, Xing C, Kim WJ, Lee S, et al, (2009) Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke 40: 2836-2842.
33. Schreibelt G, Kooij G, Reijerkerk A, van Doorn R, Gringhuis SI, van der Pol S, et al, (2007) Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J 21: 3666-3676.
34. Schroepfer GJ Jr, (2000) Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 80: 361-554.
35. Schulz E, Dopheide J, Schuhmacher S, Thomas SR, Chen K, Daiber A, et al, (2008) Suppression of the JNK pathway by induction of a metabolic stress response prevents vascular injury and dysfunction. Circulation 118: 1347-1357.
36. Sedarous M, Keramaris E, O'Hare M, Melloni E, Slack RS, Elce JS, et al, (2003) Calpains mediate p53 activation and neuronal death evoked by DNA damage. J Biol Chem 278: 26031-26038.
37. Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, et al, (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 9: 487-488.
38. Takenaga Y, Takagi N, Murotomi K, Tanonaka K, Takeo S, (2009) Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. J Cereb Blood Flow Metab 29: 1099-1108.
39. Tsubokawa T, Solaroglu I, Yatsushige H, Cahill J, Yata K, Zhang JH, (2006) Cathepsin and calpain inhibitor E64d attenuates matrix metalloproteinase-9 activity after focal cerebral ischemia in rats. Stroke 37: 1888-1894.
40. Wildenberg GA, Dohn MR, Carnahan RH, Davis MA, Lobdell NA, Settleman J, Reynolds AB, (2006) p120-catenin and p190RhoGAP regulate cell-cell adhesion by coordinating antagonism between Rac and Rho. Cell 127: 1027-1039.
41. Zechariah A, ElAli A, Hermann DM, (2010) Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation and DNA fragmentation after focal cerebral ischemia in mice. Stroke 41: 1008-1012.
42. Zhao BQ, Ikeda Y, Ihara H, Urano T, Fan W, Mikawa S, et al, (2004) Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice. Blood 103: 2610-2616.
43. Zhao BQ, Wang S, Kim HY, Storrie H, Rosen BR, Mooney DJ, et al, (2006) Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med 12: 441-445.